UNSPSC 51342904: Vidarabine

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3XQD2MEW34, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but generally known as vidarabine, which bears US NIH Compound Identifier 191. European Medicines Agency schedules Vidarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00047MIG.

UNSPSC 51342904 Vidarabine, a Commodity code, does not align with recent state and local procurement activity indexed under it. The two posted opportunities in the dataset—an Illinois Department of Public Health pharmaceutical warehouse order for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems—fall outside the scope of vidarabine, an antiviral medication with limited modern clinical use. The code appears to capture pharmaceutical supply chain activity broadly, but the specific products actually being solicited do not match the nominal commodity. State and local health departments and county public health entities are the primary issuing bodies visible in the dataset, procuring through cooperative purchasing vehicles (the Illinois award ran through the MMCAP Infuse consortium) and competitive IFB processes.

Activity is geographically sparse and recent examples are concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2.999 million pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through an IFB on August 28, 2026, with a 12-month initial term and two optional renewal years. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023—the date discrepancy suggests a data-quality issue in the opportunity record. The Illinois procurement did not include set-asides or domestic product preferences; the Seminole County procurement carried no explicit disadvantaged-enterprise designations but required E-Verify compliance and drug-free workplace certification. The code shows minimal activity indexed to vidarabine specifically, signaling either low state and local demand for the product or systematic miscoding of pharmaceutical procurements at the commodity level.